Inorganic Nanoparticles Research Articles

Technetium-99m: a Nanomaterial Perspective

The radiolabeling of nanomaterials with technetium-99m (99mTc) has emerged as a promising strategy for integrating the advantages of nanotechnology and nuclear medicine for both diagnostic and therapeutic applications. This comprehensive review aims to provide an indepth overview of the current state-of-the-art in the radiolabeling of nanomaterials with 99mTc. The exploration encompasses synthesis methods, labeling mechanisms, biological assessments, physicochemical characterizations, and clinical applications of 99mTc-labeled nanomaterials. Diverse categories of nanomaterials are addressed, including organic and inorganic nanoparticles, lipid- and protein-based nanosystems, as well as various carbon nanomaterials. Additionally, the review addresses challenges inherent in this evolving field, such as the stability of the radiolabel, potential nanomaterial toxicity, and regulatory considerations. The discussion is concluded by exploring promising future perspectives and potential areas for research development in the realm of 99mTc-labeled nanomaterials.

A comprehensive review on the classification, synthesis, characterization of nanopartices and their therapeutic impact

The main topic of the document is nanotechnology and the use of nanoparticles in various fields. The document introduces nanotechnology and defines nanoparticles as particles with lengths between 1 nm and 100 nm. Nanoparticles are classified as zero-dimensional nanomaterials and have distinct physico-chemical characteristics compared to bulk materials due to their small size and high surface to volume ratio. Nanoparticles have gained attention in technological breakthroughs due to their adjustable properties and potential applications in drug delivery. The document also discusses the different types of nanoparticles, including organic, inorganic, carbon-based, and herbal nanoparticles. Organic nanoparticles, such as micelles and liposomes, are often used for drug delivery. Inorganic nanoparticles, such as silver and gold nanoparticles, find applications in cosmetics and medicine. Carbon-based nanoparticles, including graphene and carbon nanotubes, have various uses in fields such as energy storage and sensors. The document also mentions the use of herbal nanoparticles derived from plant extracts. Additionally, the document highlights the concept of green synthesis, which offers advantages in terms of environmental friendliness and sustainability. Overall, the review provides an overview of the significance and potential applications of nanoparticles in different industries.

Protein Cage Directed Assembly of Binary Nanoparticle Superlattices.

Inorganic nanoparticles can be assembled into superlattices with unique optical and magnetic properties arising from collective behavior. Protein cages can be utilized to guide this assembly by encapsulating nanoparticles and promoting their assembly into ordered structures. However, creating ordered multi-component structures with different protein cage types and sizes remains a challenge. Here, the co-crystallization of two different protein cages (cowpea chlorotic mottle virus and ferritin) characterized by opposing surface charges and unequal diameter is shown. Precise tuning of the electrostatic attraction between the cages enabled the preparation of binary crystals with dimensions up to several tens of micrometers. Additionally, binary metal nanoparticle superlattices are achieved by loading gold and iron oxide nanoparticles inside the cavities of the protein cages. The resulting structure adopts an AB2 FCC configuration that also impacts the dipolar coupling between the particles and hence the optical properties of the crystals, providing key insight for the future preparation of plasmonic and magnetic nanoparticle metamaterials.

Graphene, graphene oxide or modified graphene in polyaniline based nanocomposites—features and technical highlights

Polyaniline is a remarkable conjugated polymer having valuable structural and physical characteristics. Nevertheless, polyaniline has poor solubility and structural durability which had limited its practical utilization. Consequently, polyaniline has been reinforced with carbonaceous and inorganic nanoparticles to enhance its processability and physical properties, such as electrical/thermal conductivity and thermal/mechanical stability. Accordingly, polyaniline has been applied as a valuable matrix material to form nanocomposites with graphene which is a one atom thick nanosheet of hexagonally arranged carbon atoms. Subsequently, graphene as well as modified graphene forms have been utilized as important nanoadditives for the polyaniline matrix. This state-of-the-art review article has been designed to investigate the fabrication, characteristics, and applications of the polyaniline and graphene/modified graphene based nanomaterials. Potential enhancements in the physical characteristics of the pristine polyaniline upon graphene reinforcement seemed to be reliant upon the matrix-nanofiller interactions, interface formation, and synergetic effects between polyaniline-graphene. Subsequently, practical aspects of the polyaniline/graphene nanocomposites have been discussed regarding their applications in the fields of solar cells, supercapacitors, and sensors. According to the literature analysis, dye sensitized solar cell based on polyaniline/graphene and polyaniline/graphene oxide exhibited superior power conversion efficiencies ∼2.0-7.6 % and open circuit voltage ∼500-800 mV. Supercapacitor electrodes based on polyaniline/graphene oxide and polyaniline/reduced graphene oxide showed significantly high values of specific capacitance and capacitance retention of ∼1100-1900 Fg−1 and ∼80-98 %, respectively, during >5000-6000 cycles. Besides, the polyaniline/graphene oxide depicted superior sensitivity and response time for gas sensors (∼20 % and 50 s, respectively) and humidity sensors (>90 % and 4-7 s, respectively) and low detection limits for biosensors.

Recent Advancements in Cancer RNA-interference Therapy with Nanotechnology Strategies

Cancer is a global challenge, and genetics play a major role in onsets and in designing the next generation of cancer therapies. One of the key approaches is the downregulation of genes through RNA interference (RNAi) which has been proposed as a promising tool for controlling cancer-causing genes by employing a complementary base-pairing mechanism. Crucial tools in RNAi; small interfering RNA (siRNA), and microRNA (miRNA) have been extensively utilized in cancer therapy. Despite their discovery nearly two decades ago, only a handful of RNAi-based products have recently gained approval from regulatory authorities like the FDA, principally due to inherent limitations. The efficacy of RNAi therapies is significantly hindered by barriers related to absorption, distribution, metabolism, and excretion, leading to rapid elimination from the systemic circulation before reaching the cytosol of targeted cells. Nevertheless, RNAi therapeutics hold immense promise in various diseases, especially in various types of cancer. Overcoming these challenges demands the design of suitable drug delivery systems and the implementation of strategies aimed at enhancing pharmacokinetic parameters associated with RNAi therapies. Nanotechnology-based vehicles such as polymer-based nanoparticles, lipid nanoparticles, liposomes, dendrimers, and inorganic nanoparticles may serve as efficient carriers for targeting RNAi therapies to their desired sites. This review discusses the recent advances in nanotechnology strategies for RNAi delivery, with the overarching objective of facilitating effective targeting and gene silencing for the advancement of RNAi in cancer therapy.

Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment.

Proteolysis targeting chimeras (PROTACs) represent a transformative class of therapeutic agents that leverage the intrinsic protein degradation machinery to modulate the hemostasis of key disease-associated proteins selectively. Although several PROTACs have been approved for clinical application, suboptimal therapeutic efficacy and potential adverse side effects remain challenging. Benefiting from the enhanced targeted delivery, reduced systemic toxicity, and improved bioavailability, nanomedicines can be tailored with precision to integrate with PROTACs which hold significant potential to facilitate PROTAC nanomedicines (nano-PROTACs) for clinical translation with enhanced efficacy and reduced side effects. In this review, we provide an overview of the recent progress in the convergence of nanotechnology with PROTAC design, leveraging the inherent properties of nanomaterials, such as lipids, polymers, inorganic nanoparticles, nanohydrogels, proteins, and nucleic acids, for precise PROTAC delivery. Additionally, we discuss the various categories of PROTAC targets and provide insights into their clinical translational potential, alongside the challenges that need to be addressed.

Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy

Nucleic acid therapeutics are promising alternatives to conventional anti-cancer therapy, such as chemotherapy and radiation therapy. While conventional therapies have limitations, such as high side effects, low specificity, and drug resistance, nucleic acid therapeutics work at the gene level to eliminate the cause of the disease. Nucleic acid therapeutics treat diseases in various forms and using different mechanisms, including plasmid DNA (pDNA), small interfering RNA (siRNA), anti-microRNA (anti-miR), microRNA mimics (miRNA mimic), messenger RNA (mRNA), aptamer, catalytic nucleic acid (CNA), and CRISPR cas9 guide RNA (gRNA). In addition, nucleic acids have many advantages as nanomaterials, such as high biocompatibility, design flexibility, low immunogenicity, small size, relatively low price, and easy functionalization. Nucleic acid therapeutics can have a high therapeutic effect by being used in combination with various nucleic acid nanostructures, inorganic nanoparticles, lipid nanoparticles (LNPs), etc. to overcome low physiological stability and cell internalization efficiency. The field of nucleic acid therapeutics has advanced remarkably in recent decades, and as more and more nucleic acid therapeutics have been approved, they have already demonstrated their potential to treat diseases, including cancer. This review paper introduces the current status and recent advances in nucleic acid therapy for anti-cancer treatment and discusses the tasks and prospects ahead.

Biomimetic Nanoparticles for Basic Drug Delivery.

Biomimetic nanoparticles (BMNPs) are innovative nanovehicles that replicate the properties of naturally occurring extracellular vesicles, facilitating highly efficient drug delivery across biological barriers to target organs and tissues while ensuring maximal biocompatibility and minimal-to-no toxicity. BMNPs can be utilized for the delivery of therapeutic payloads and for imparting novel properties to other nanotechnologies based on organic and inorganic materials. The application of specifically modified biological membranes for coating organic and inorganic nanoparticles has the potential to enhance their therapeutic efficacy and biocompatibility, presenting a promising pathway for the advancement of drug delivery technologies. This manuscript is grounded in the fundamentals of biomimetic technologies, offering a comprehensive overview and analytical perspective on the preparation and functionalization of BMNPs, which include cell membrane-coated nanoparticles (CMCNPs), artificial cell-derived vesicles (ACDVs), and fully synthetic vesicles (fSVs). This review examines both "top-down" and "bottom-up" approaches for nanoparticle preparation, with a particular focus on techniques such as cell membrane coating, cargo loading, and microfluidic fabrication. Additionally, it addresses the technological challenges and potential solutions associated with the large-scale production and clinical application of BMNPs and related technologies.

Magnetic Nanoparticles in Biopolymer Fibers: Fabrication Techniques and Characterization Methods.

Hybrid nanocomposites combining biopolymer fibers incorporated with nanoparticles (NPs) have received increasing attention due to their remarkable characteristics. Inorganic NPs are typically chosen for their properties, such as magnetism and thermal or electrical conductivity, for example. Meanwhile, the biopolymer fiber component is a backbone, and could act as a support structure for the NPs. This shift towards biopolymers over traditional synthetic polymers is motivated by their sustainability, compatibility with biological systems, non-toxic nature, and natural decomposition. This study employed the solution blow spinning (SBS) method to obtain a nanocomposite comprising poly(vinyl pyrrolidone), PVA, and gelatin biodegradable polymer fibers incorporated with magnetic iron oxide nanoparticles coated with poly(acrylic acid), PAA2k, coded as γ-Fe2O3-NPs-PAA2k. The fiber production process entailed a preliminary investigation to determine suitable solvents, polymer concentrations, and spinning parameters. γ-Fe2O3-NPs were synthesized via chemical co-precipitation as maghemite and coated with PAA2k through the precipitation-redispersion protocol in order to prepare γ-Fe2O3-NPs-PAA2k. Biopolymeric fibers containing coated NPs with sub-micrometer diameters were obtained, with NP concentrations ranging from 1.0 to 1.7% wt. The synthesized NPs underwent characterization via dynamic light scattering, zeta potential analysis, and infrared spectroscopy, while the biopolymer fibers were characterized through scanning electron microscopy, infrared spectroscopy, and thermogravimetric analysis. Overall, this study demonstrates the successful implementation of SBS for producing biopolymeric fibers incorporating iron oxide NPs, where the amalgamation of materials demonstrated superior thermal behavior to the plain polymers. The thorough characterization of the NPs and fibers provided valuable insights into their properties, paving the way for their potential applications in various fields such as biomedical engineering, environmental remediation, and functional materials.

Functional inorganic nanoparticles in cancer: Biomarker detection, imaging, and therapy

Cancer poses a major global public health challenge. Developing more effective early diagnosis methods and efficient treatment techniques is crucial to enhance early detection sensitivity and treatment outcomes. Nanomaterials offer sensitive, accurate, rapid, and straightforward approaches for cancer detection, diagnosis, and treatment. Inorganic nanoparticles are widely used in medicine because of their high stability, large specific surface area, unique surface properties, and unique quantum size effects. Functional inorganic nanoparticles involve modifying inorganic nanoparticles to enhance their physical properties, enrichment capabilities, and drug-loading efficiency and to minimize toxicity. This Review provides an overview of various types of inorganic nanoparticles and their functionalization characteristics. We then discuss the progress of functional inorganic nanoparticles in cancer biomarker detection and imaging. Furthermore, we discuss the application of functional inorganic nanoparticles in radiotherapy, chemotherapy, gene therapy, immunotherapy, photothermal therapy, photodynamic therapy, sonodynamic therapy, and combination therapy, highlighting their characteristics and advantages. Finally, the toxicity and potential challenges of functional inorganic nanoparticles are analyzed. The purpose of this Review is to explore the application of functional inorganic nanoparticles in diagnosing and treating cancers, while also presenting a new avenue for cancer diagnosis and treatment.

Therapeutic Efficacy of Nanocarrier‐Mediated Inhalable Gene Transfection for Lung Cancer

AbstractLung cancer is now the leading cause of cancer‐related mortality, eclipsing all other cancer forms, and of all lung malignancies, non‐small cell lung cancer (NSCLC) makes up around 85%. Recently, the use of vectors in gene therapy besides chemotherapy to treat malignancies brought on by gene mutations has gained prominence. Therapeutic molecule inhalation is a direct approach to lung‐targeted medication delivery with low nonspecific toxicity and limited drug exposure. Treatment for lung cancer with chemotherapy and immunotherapy can be aided by inhalable nanomedicine through advanced mechanisms. Viral and nonviral vectors, such as lipid‐based nanoparticles, polymeric nanoparticles, and inorganic nanoparticles, have all drawn a lot of interest for their ability to increase effects and decrease side effects. Nanocarriers have a significant impact on targeted gene delivery, bioavailability, stability, and residence in target areas. The inhaled pulmonary gene delivery approach, when combined with nanomedicine, will offer a noninvasive and successful way to treat lung cancer by taking use of the physiological properties of the lung. The authors have majorly used data from PubMed and Google Scholar to obtain the relevant information required for the article. In general, this review concentrates on the usage of various inhalable nanocarriers, which might serve as an inspiration for the creation and deployment of more potent genetic therapy for the treatment of lung cancer.

Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia.

Acute myeloid leukemia (AML) is a common and catastrophic hematological neoplasm with high mortality rates. Conventional therapies, including chemotherapy, hematopoietic stem cell transplantation (HSCT), immune therapy, and targeted agents, have unsatisfactory outcomes for AML patients due to drug toxicity, off-target effects, drug resistance, drug side effects, and AML relapse and refractoriness. These intrinsic limitations of current treatments have promoted the development and application of nanomedicine for more effective and safer leukemia therapy. In this review, the classification of nanoparticles applied in AML therapy, including liposomes, polymersomes, micelles, dendrimers, and inorganic nanoparticles, is reviewed. In addition, various strategies for enhancing therapeutic targetability in nanomedicine, including the use of conjugating ligands, biomimetic-nanotechnology, and bone marrow targeting, which indicates the potential to reverse drug resistance, are discussed. The application of nanomedicine for assisting immunotherapy is also involved. Finally, the advantages and possible challenges of nanomedicine for the transition from the preclinical phase to the clinical phase are discussed.

Advancements in Nanoparticle-Based Precision Drug Delivery: A Review of Development and Optimization for Targeted Therapy in Preclinical Models

In recent years, the widespread adoption of nanoparticles has expanded across a broad spectrum of clinical domains. These nanoparticles have been specifically engineered to address the limitations associated with conventional therapeutics and to navigate various biological barriers—ranging from systemic to cellular levels—that manifest heterogeneity across different patient populations and disease states. The advent of precision treatments, wherein interventions are tailored to individual patients, has contributed to mitigating this variability among patients. Nonetheless, the predominant focus in current nanoparticle research remains on enhancing the uniformity of delivery systems. The realization of precision medicine appears imminent as lipid-based, polymeric, and inorganic nanoparticles are increasingly crafted with heightened precision, facilitating more individualized approaches to medication delivery. In this review, we delve into the advanced designs of nanoparticles employed in both precision and generalized applications, offering insights into their potential to advance precision medicine. Our discussion centers on the innovations in nanoparticle design aimed at overcoming various delivery challenges, suggesting that ingenious nanoparticle engineering holds promise for enhancing performance across a broad spectrum of delivery applications and facilitating tailored designs for specific therapeutic targets, ultimately leading to improved patient outcomes.

Needle Tip Tracking through Photoluminescence for Minimally Invasive Surgery.

Minimally invasive surgery continues to prioritize patient safety by improving imaging techniques and tumor detection methods. In this work, an all-optical alternative to the current image based techniques for in vitro minimally invasive procedures has been explored. The technique uses a highly fluorescent marker for the surgical needle to be tracked inside simulated tissues. A series of markers were explored including inorganic (Perovskite and PbS) and organic (carbon dots) nanoparticles and organic dye (Rhodamine 6G) to identify layers of different stiffnesses within a tissue. Rhodamine 6G was chosen based on its high fluorescence signal to track 3D position of a surgical needle in a tissue. The needle was tracked inside homogeneous and inhomogeneous gelatin tissues successfully. This exploratory study of tissue characterization and needle tip tracking using fluorescent markers or photoluminescence technique show potential for real-time application of robot-assisted needle insertions during in vivo procedures.

Methods for Fabrication of Self/Free Standing Nanocellulose (NC)-Nano Montmorillonite (N-MMT) Composite Films/Sheets — A Review

Plastic pollution looms large as a formidable foe to the environment. Enter cellulose nanofibers, the shining stars in the quest for innovative, eco-friendly paper-based packaging that is not just renewable, but also recyclable and biodegradable. These cellulose wonders boast impressively low oxygen permeability, but when it comes to water vapor, they fall short compared to traditional packaging plastics like LDPE. To tackle this challenge, researchers have been crafting composites by blending cellulose nanofibers with inorganic nanoparticles, such as Montmorillonite clay, which helps to curb water vapor permeability. However, this clever addition comes with a catch — it further complicates the already tricky drainage process during layer formation via vacuum filtration. This review delves into the complex world of nano cellulose-nano-MMT (Montmorillonite) composites, examining their preparation processes, unique characteristics, wide-ranging uses, and their significant contribution to promoting circular economy principles. By combining cellulose nanomaterials with MMT, a synergistic approach is taken to develop a new composite material with improved mechanical, thermal, and barrier properties. Various fabrication techniques are explored, including solution blending, in-situ polymerization, and electrospinning, allowing for customized design and optimization of the composite material. The review discusses how the nano cellulose-MMT composite demonstrates enhanced mechanical strength, thermal stability, and barrier properties, positioning it as a sustainable option compared to traditional materials. The review also showcases the diverse applications of these nano-composites in fields like packaging, biomedical devices, and environmental cleanup, emphasizing their alignment with circular economy principles. By examining the entire life cycle of these composites, from production to use and eventual disposal or recycling, the review underscores their role in supporting a circular economy. In light of the ongoing efforts by the scientific community and various industries to identify environmentally sustainable solutions, it is imperative to comprehend the synthesis, properties, and applications of nano cellulose-MMT composites. This understanding is essential for advancing sustainable processing for green material development.

BACTERIAL CELLULOSE-BASED COMPOSITES: RECENT TRENDS IN PRODUCTION METHODS AND APPLICATIONS

Bacterial cellulose (BC) has attracted significant attention due to its distinct structural attributes and remarkable physico-mechanical properties, making it highly popular in biomedical applications, such as artificial skin, blood vessels, tissue scaffolds, and wound dressings. However, its widespread application in a variety of fields is often limited by poor mechanical properties and functional characteristics. The development of BC-based composites by incorporating synthetic materials has been widely investigated to address these limitations. This review paper summarizes the fabrication strategies for BC composites in-situ and ex-situ methods for their development, and highlights their wide range of applications in diverse fields. Various strategies have been designed for the synthesis of BC composite functionalized materials, tailored to the specific nature of their intended application. In the synthesis of BC composites, either in-situ addition of reinforcing materials to the synthetic media or ex-situ incorporation of these materials into the microfilaments of the BC microfilaments is primarily involved. A wide range of materials have been used as reinforced materials, ranging from organic polymers to inorganic nanoparticles. These composite materials have the potential to be used for tissue regeneration, wound healing, enzyme immobilization, and the development of medical devices. Recent years have seen the development of BC composites incorporating conductive materials, being used in the production of various electrical products, such as biocatalysts, enzymes, e-papers, displays, electrical instruments, and optoelectronic devices. In summary, the synthesis of BC composites and their applications offers a path for producing advanced biomaterials with enhanced properties and diverse functionalities, exploring their potential as environmentally friendly and versatile materials applicable across multiple sectors.

Elucidating the potential of bimetallic mixed metal oxide (FeO/NiO) in fusion with pristine and N- and S-doped graphene oxide for biomedical applications

Antimicrobial resistance is attributed to acquiring new mechanisms by microbes to combat antimicrobial agents, highlighting the necessity to discover new antimicrobial agents to protect human health. Graphene and its derivatives have shown antimicrobial potential due to their physical and chemical distinctive features. Potent antibacterial properties were observed by decorating the surface of graphene and its derivatives with inorganic nanoparticles, such as metal and metal oxide. In an attempt to reliably overcome antimicrobial resistance, the multifunctional nanocomposites, including FeO/NiO, FeO/NiO/GO, FeO/NiO/N-GO, and FeO/NiO/S-GO, were synthesized using a wet chemical method. Accordingly, the structural analysis was performed using X-ray diffraction (XRD), infrared spectroscopy (IR), energy dispersive X-ray (EDX), ultraviolet-visible spectroscopy (UV–vis), and scanning electron microscopy (SEM). For antibacterial potential, the synthesized nanocomposites were tested against non-resistant and resistant strains of bacteria. Notably, moderate antibacterial potential was found for FeO/NiO/N-GO nanocomposite with a MIC value of 12.5 μg/mL, compared to the MIC of pure Ciprofloxacin, a positive control, with a value of 1.25 μg/mL. Toward antifungal potential, the synthesized nanocomposites were assessed against various spores of fungal strains. In this regard, the synthesized nanocomposites were demonstrated as potent antifungal agents. Among the synthesized nanocomposites, FeO/NiO and FeO/NiO/S-GO exhibited the highest ZOI against Aspergillus flavus. Additionally, the activity of these nanocomposites was evaluated by means of total reducing power (TRP), total antioxidant capacity (TAC), and free radical scavenging. Further, the antioxidant, brine shrimp lethality, and hemolytic potential of the synthesized nanocomposites were evaluated to compare their effectiveness. According to brine shrimp lethality, all synthesized nanocomposites were sufficiently active, with a calculated median lethal concentration (LC50) showing ≥ 50 % mortality. The obtained results provide a promising base for the incorporation of nanocomposites in pharmaceutical and biomedical products.

Traditional Strategies and Cutting-Edge Technologies Used for Plant Disease Management: A Comprehensive Overview

Agriculture plays a fundamental role in ensuring global food security, yet plant diseases remain a significant threat to crop production. Traditional methods to manage plant diseases have been extensively used, but they face significant drawbacks, such as environmental pollution, health risks and pathogen resistance. Similarly, biopesticides are eco-friendly, but are limited by their specificity and stability issues. This has led to the exploration of novel biotechnological approaches, such as the development of synthetic proteins, which aim to mitigate these drawbacks by offering more targeted and sustainable solutions. Similarly, recent advances in genome editing techniques—such as meganucleases (MegNs), zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)—are precise approaches in disease management, but are limited by technical challenges and regulatory concerns. In this realm, nanotechnology has emerged as a promising frontier that offers novel solutions for plant disease management. This review examines the role of nanoparticles (NPs), including organic NPs, inorganic NPs, polymeric NPs and carbon NPs, in enhancing disease resistance and improving pesticide delivery, and gives an overview of the current state of nanotechnology in managing plant diseases, including its advantages, practical applications and obstacles that must be overcome to fully harness its potential. By understanding these aspects, we can better appreciate the transformative impact of nanotechnology on modern agriculture and can develop sustainable and effective strategies to mitigate plant diseases, ensuring enhanced agricultural productivity.

In Vivo Optogenetics Based on Heavy Metal-Free Photon Upconversion Nanoparticles.

Photon upconversion (UC) from red or near-infrared (NIR) light to blue light is promising for in vivo optogenetics. However, the examples of in vivo optogenetics have been limited to lanthanide inorganic UC nanoparticles, and there have been no examples of optogenetics without using heavy metals. Here the first example of in vivo optogenetics using biocompatible heavy metal-free TTA-UC nanoemulsions is shown. A new organic TADF sensitizer, a boron difluoride curcuminoid derivative modified with a bromo group, can promote intersystem crossing to the excited triplet state, significantly improving TTA-UC efficiency. The TTA-UC nanoparticles formed from biocompatible surfactants and methyl oleate acquire water dispersibility and remarkable oxygen tolerance. By combining with genome engineering technology using the blue light-responding photoactivatable Cre-recombinase (PA-Cre), TTA-UC nanoparticles promote Cre-reporter EGFP expression in neurons in vitro and in vivo. The results open new opportunities toward deep-tissue control of neural activities based on heavy metal-free fully organic UC systems.

Developments and Applications of Molecularly Imprinted Polymer-Based In-Tube Solid Phase Microextraction Technique for Efficient Sample Preparation.

Despite advancements in the sensitivity and performance of analytical instruments, sample preparation remains a bottleneck in the analytical process. Currently, solid-phase extraction is more widely used than traditional organic solvent extraction due to its ease of use and lower solvent requirements. Moreover, various microextraction techniques such as micro solid-phase extraction, dispersive micro solid-phase extraction, solid-phase microextraction, stir bar sorptive extraction, liquid-phase microextraction, and magnetic bead extraction have been developed to minimize sample size, reduce solvent usage, and enable automation. Among these, in-tube solid-phase microextraction (IT-SPME) using capillaries as extraction devices has gained attention as an advanced "green extraction technique" that combines miniaturization, on-line automation, and reduced solvent consumption. Capillary tubes in IT-SPME are categorized into configurations: inner-wall-coated, particle-packed, fiber-packed, and rod monolith, operating either in a draw/eject system or a flow-through system. Additionally, the developments of novel adsorbents such as monoliths, ionic liquids, restricted-access materials, molecularly imprinted polymers (MIPs), graphene, carbon nanotubes, inorganic nanoparticles, and organometallic frameworks have improved extraction efficiency and selectivity. MIPs, in particular, are stable, custom-made polymers with molecular recognition capabilities formed during synthesis, making them exceptional "smart adsorbents" for selective sample preparation. The MIP fabrication process involves three main stages: pre-arrangement for recognition capability, polymerization, and template removal. After forming the template-monomer complex, polymerization creates a polymer network where the template molecules are anchored, and the final step involves removing the template to produce an MIP with cavities complementary to the template molecules. This review is the first paper to focus on advanced MIP-based IT-SPME, which integrates the selectivity of MIPs into efficient IT-SPME, and summarizes its recent developments and applications.